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The 2012 year has already witnessed several scientific 
breakthroughs and discoveries. Diabetes, caused by 
destruction of insulin-producing beta-cells, may require 
life long injections of insulin and even that does not 
preclude diabetic complications. Transplantation of 
beta-cells is one of the options but transplant rejection is 
a problem. Could we collect skin cells from a diabetic 
patient, induce them to become stem cells and then 
induce these stem cells to become beta-cells. Given that 
diabetic cells suffer from metabolic abnormalities, this 
may seem to be impossible, especially in elderly 
patients with type II diabetes. But this is exactly what 
was reported in this issue of Aging. In elderly type 2 
diabetes patients, reprogramming of keratinocytes 
ensures a senescence-privileged status yielding stem 
cells proficient for regenerative applications (see 
Ohmine et al, Aging 2012; 4: this issue). Type II 
diabetic patients suffer from insulin-resistance. Insulin 
resistance may be caused by feedback inhibition of 
signals by over-activated mTOR. And mTOR is 
involved in aging. Not surprisingly, cells from old 
individuals can be signal-resistant. As reported in this 
issue of Aging by Nakamura et al, age-related resistance 
of skeletal muscle-derived progenitor cells to SPARC 
(an autocrine differentiation factor) may explain a shift 
from myogenesis to adipogenesis (Aging 2012; 4: this 
issue).  This in turn may explain age-related sarcopenia. 
Interestingly, inhibition of mTOR may decrease 
sarcopenia (Aging 201; 3:83-84.) probably due to 
restoration of signal-sensitivity. The challenge is to 
restore signal-sensitivity pharmacologically, using 
pulse-treatment with rapamycin as suggested previously 
(Rejuvenation Res. 2008;11:801-808). Alternatively, 
calorie restriction may also restore the responsiveness to 
signals and extend lifespan. As reported in this issue of 
Aging by Streeper et al, the deficiency of the 
triglyceride synthesis enzyme acyl CoA:diacylglycerol 
acyltransferase 1 (DGAT1), which promotes leanness, 
also extends longevity without limiting food intake. 
Such mice are spared from age-related obesity, elevated 
IGF-1 and inflammation in white adipose tissue. This 
was accompanied by increased mean and maximal life 
spans of 25% and 10%, respectively (Aging 2012; 4: 
this issue). It was recently shown that CR decreased a 
number of senescent cells in the organism (Aging 2010; 
2:555-566). In this issue of Aging, Campisi and co-
workers demonstrated that mitochondrial oxidative 
stress   caused  by   Sod2  deficiency  promotes  cellular  
 
 
                                                    Editorial 
 
 
 
senescence and aging phenotypes in the skin (Velarde et 
al. Aging 2012; 4: this issue). This excellent model may 
be helpful to investigate whether CR might blunt the 
effect. As reported by Altilia et al in this issue of Aging, 
cells bearing p53R72 accumulate lower amount of 
mtDNA damage. This paper suggests that the 
polymorphism of p53 at codon 72 affects the 
accumulation of mtDNA mutations and may contribute 
to in vivo accumulation of mtDNA mutations (Aging 
2012; 4: this issue). Finally, age-related macular 
degeneration (AMD) and cataract are common age-
related diseases in humans. In this issue of Aging 
Korbolina et al reported quantitative trait loci (QTLs), 
which affect early-onset cataract and retinopathy in 
senescence-accelerated OXYS rats, comparable to 
human AMD and senile cataract. The 2012 year is just 
started. We expect to see more discoveries in 
forthcoming months. 
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